Drug
Dapagliflozin clinical trials
Also written Forxiga, Farxiga, BMS-512148 and BR3006.
- studies test it
- 489
- open now
- 118
- in phase 3
- 133
- first study started
- 2005
Keep track of what changes. Save the dapagliflozin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
488 studies that test it; most in 2022 (56); 1 more planned to start later
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 5 |
| 2008 | 8 |
| 2009 | 12 |
| 2010 | 14 |
| 2011 | 4 |
| 2012 | 6 |
| 2013 | 2 |
| 2014 | 14 |
| 2015 | 27 |
| 2016 | 29 |
| 2017 | 22 |
| 2018 | 16 |
| 2019 | 29 |
| 2020 | 32 |
| 2021 | 42 |
| 2022 | 56 |
| 2023 | 42 |
| 2024 | 47 |
| 2025 | 42 |
| 2026 | 35 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 6
- Phase 1
- 69
- Phase 2
- 111
- Phase 3
- 133
- Phase 4
- 163
- No phase
- 36
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 136 · Other 353
AstraZeneca (108) · The University of Texas Health Science Center at San Antonio (10) · Mansoura University (9) · Chong Kun Dang Pharmaceutical (7) · University of Guadalajara (6) · University Medical Center Groningen (5) · Ain Shams University (5) · University of Campinas, Brazil (5)
Often tested with
Tested in the same studies.
Metformin (35) · Empagliflozin (18) · Saxagliptin (15) · Semaglutide (10) · Sitagliptin (10) · Pioglitazone (9) · ZD4054 (6) · Exenatide (6)
Studies
Open first, then newest update. How each study uses dapagliflozin is read from its arms, and is right about nine times in ten.
Testing it · 489
- Effect of SGLT2 Inhibitor on Metabolic-Dysfunction-Associated Fatty Liver Disease in Patients With Insulin ResistanceNot yet recruitingPhase 4Sherihan AboElyazed Mohamed KhalilNCT07891234Written as Dapagliflozin 5Mg Tab
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinRecruitingPhase 3AstraZenecaNCT06677060Written as Baxdrostat and dapagliflozin
- dApagliflozin SC0062 and Prevention of Renal Injury; a Randomized EvaluationNot yet recruitingPhase 2University Medical Center GroningenNCT06072326Written as Dapagliflozin (Forxiga®)
- Phase 3 Clinical Trial With Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult PatientsRecruitingPhase 3University Hospital GoettingenNCT05944016Written as Dapagliflozin
- Rezdiffra® With Concomitant Therapies Commonly Used to Treat Comorbidities in Adults With MASH and F2-F3 FibrosisRecruitingPhase 4Madrigal Pharmaceuticals, Inc.NCT07848191Written as FARXIGA/dapagliflozin
- Clinical Investigation of the Cardioprotective Effect of Early Administration of SGLT2 in Patients Presented With AMIRecruitingNot applicableMohammad Hussien Tantawy SolimanNCT06009874Written as Dapagliflozin 10mg Tab
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationPhase 4Baylor Research InstituteNCT07547878Written as Farxiga
- STunning in Acute Myocardial Infarction - BASRecruitingPhase 4Vastra Gotaland RegionNCT06562582Written as Dapagliflozin Oral Product
- Evaluation of Dapagliflozin and Empagliflozin as Adjunctive Therapy to Methotrexate in Patients With Rheumatoid ArthritisNot yet recruitingPhase 2Al-Azhar UniversityNCT07864688Written as Dapagliflozin
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureRecruitingPhase 3AstraZenecaNCT06742723Written as Baxdrostat/dapagliflozin
- A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)RecruitingPhase 3AstraZenecaNCT07624305Written as Balcinrenone/dapagliflozin
- Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)RecruitingNot applicableThe University of Texas Health Science Center at San AntonioNCT02969798Written as Dapagliflozin
- A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health RecordRecruitingPhase 4Herlev and Gentofte HospitalNCT06642272Written as Dapagliflozin 10 MG
- Manganese-enhanced Magnetic Resonance Imaging in Takotsubo CardiomyopathyRecruitingNot applicableUniversity of EdinburghNCT07491718Written as Dapagliflozin (10mg Tab)
- SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With PrediabetesRecruitingPhase 4University Hospital TuebingenNCT06054035Written as Dapagliflozin (Forxiga®)
- Regression in Left Ventricular Hypertrophy and Fibrosis in Aortic StenosisNot yet recruitingPhase 2University College, LondonNCT07539259Written as Dapagliflozin (DAPA)
- Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary SyndromeNot yet recruitingPhase 2/3Tanta UniversityNCT07810998Written as Dapagliflozin (10mg Tab)
- A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes MellitusRecruitingPhase 3AstraZenecaNCT07662044Written as Dapagliflozin
- A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes MellitusRecruitingPhase 3AstraZenecaNCT07662109Written as Dapagliflozin
- SGLT2 Inhibitors in Geographic AtrophyRecruitingPhase 2Washington University School of MedicineNCT07174687Written as Dapagliflozin
See all 489 studies that test dapagliflozin →
Given in every arm · 31 — dapagliflozin is usual care beside what is tested
- SGLT2i, Pioglitazone, and Ketone Production in T1DRecruitingPhase 3The University of Texas Health Science Center at San AntonioNCT07056699Written as Dapagliflozin 10mg Tab
- Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)RecruitingPhase 1Washington University School of MedicineNCT05521984Written as Dapagliflozin
- DP-DCT 1.0:A Comparative Clinical Study on the Effect of Dapagliflozin Combined With CGM Versus SMBG on Glycemic Control in Patients With Type 2 Diabetes Mellitus Based on the DP-DCT PlatformNot yet recruitingNot applicableThe Third Xiangya Hospital of Central South UniversityNCT07595289Written as Dapagliflozin (10mg Tab)
- POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart FailureNot yet recruitingPhase 2/3Hospital de Clinicas de Porto AlegreNCT07469722Written as Dapagliflozin (10mg Tab)
- A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 DiabetesRecruitingPhase 4Boryung Pharmaceutical Co., LtdNCT06972732Written as Dapagliflozin/Pioglitazone
- Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes MellitusRecruitingPhase 4Anemia Working Group RomaniaNCT06281899Written as Dapagliflozin 10 mg Tab
- A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA NephropathyCompletedPhase 3Travere Therapeutics, Inc.NCT03762850Written as Dapagliflozin
- Sodium-Glucose Co-Transporter-2 Inhibitors as Adjuvant Therapy With Letrozole in Induction of Ovulation in Women With Polycystic Ovarian SyndromeCompletedPhase 4Beni-Suef UniversityNCT07589075Written as Dapagliflozin 10 MG Oral Tablet [Farxiga]
- Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian SyndromeCompletedPhase 3Beni-Suef UniversityNCT06405178Written as Dapagliflozin
- Effects of Dapagliflozin, Semaglutide, and Their Combination in Heart Failure Patients With Prosthetic Heart ValvesCompletedPhase 2Kafrelsheikh UniversityNCT07610174Written as Dapagliflozin (10mg Tab)
- Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 DrugsActive, not recruitingNot applicableNazarbayev UniversityNCT07303556Written as dapagliflozin, empagliflozin, metformin
- Improving HbA1c Levels by Methylcobalamin Vitamin in Diabetic VolunteersCompletedNot applicableAl-Balqa Applied UniversityNCT06241638Written as Dapagliflozin 10mg Tab
- A Phase Ib Study of AZD5462 on Top of Dapagliflozin in Participants With Heart Failure and Moderate Renal ImpairmentTerminatedPhase 1AstraZenecaNCT06639087Written as Dapagliflozin
- The Effect of Combination of Dapagliflozin and Sildenafil in Treatment of Heart Failure Patients With Secondary Pulmonary HypertensionCompletedNot applicableFayoum UniversityNCT06778330Written as Dapagliflozin (DAPA)
- A Study to Evaluate the Safety and Efficacy of AZD5718 in Participants With Proteinuric Chronic Kidney DiseaseTerminatedPhase 2AstraZenecaNCT04492722Written as Dapagliflozin 10 mg
- Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney DiseaseCompletedPhase 2AstraZenecaNCT04595370Written as Dapagliflozin
- Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial)CompletedPhase 2AstraZenecaNCT04724837Written as Dapagliflozin
- A Phase 2b Diabetic Kidney Disease StudyCompletedPhase 2AstraZenecaNCT04170543Written as Dapagliflozin
- A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and DapagliflozinCompletedPhase 3Boryung Pharmaceutical Co., LtdNCT04885712Written as Dapagliflozin 10mg
- Combination GRA and SGLT-2i Treatment in Type 1 DiabetesCompletedPhase 1/2University of California, San DiegoNCT04545411Written as Dapagliflozin 10 MG [Farxiga]
Showing 20 of 31.
As the comparator · 23 — what is tested is compared with dapagliflozin
- A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 DiabetesRecruitingPhase 4Boryung Pharmaceutical Co., LtdNCT06972732Written as Dapagliflozin/Pioglitazone
- A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes MellitusRecruitingPhase 3Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07082114Written as Dapagliflozin (DAPA)
- Dapagliflozin on Outcomes of Rhythm Control Strategy (Pharmacological ± Interventional) in Patient with Atrial FibrillationNot yet recruitingPhase 1Assiut UniversityNCT06759909Written as Dapagliflozin (DAPA)
- Acetazolamide Versus Dapagliflozin in Acute Decompensated Heart Failure PatientsRecruitingPhase 3Helwan UniversityNCT06535529Written as Dapagliflozin 10mg
- The Effect of Short-term Insulin Intensive Therapy Based on the Application of Insulin Pump and Real-time Dynamic Glucose Monitoring Technology on Reversing the Newly Diagnosed Type 2 DiabetesRecruitingPhase 4Sun Yat-sen UniversityNCT06127433Written as Dapagliflozin
- Efficacy and Safety of LID104 in the Treatment of Type II Diabetes MellitusNot yet recruitingPhase 3EMSNCT05886088Written as Dapagliflozin
- A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With MetforminCompletedPhase 3Eli Lilly and CompanyNCT06192108Written as Dapagliflozin
- Comparing The Effect Of Empagliflozin With Dapagliflozin In Reducing Proteinuria In Diabetic Patients With Chronic Kidney Disease With eGFR More Than 45ml/Min/1.73m²CompletedNot applicableLahore General HospitalNCT07866235Written as Dapagliflozin
- Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With MetforminCompletedPhase 3Shenzhen HighTide Biopharmaceutical Ltd.NCT06415773Written as Dapagliflozin
- A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With MetforminCompletedPhase 3Shandong Suncadia Medicine Co., Ltd.NCT06589765Written as dapagliflozin tablet
- A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin TherapyCompletedPhase 4Celltrion Pharm, Inc.NCT03499704Written as Dapagliflozin
- Efficacy of FDC Regimen of Dapagliflozin/Metformin Compared to Co-administered Dual Therapy on Glycemic Control, Satisfaction and Adherence in Chinese Patients With T2DMCompletedPhase 4AstraZenecaNCT06327815Written as Dapagliflozin tablets and Metformin HCl extended-release tablets
- Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing Metformin Monotherapy in Patients with Type 2 Diabetes Who Have Inadequate Glycemic ControlCompletedPhase 4Dong-A ST Co., Ltd.NCT05743907Written as Forxiga
- The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on MetforminActive, not recruitingPhase 3Daewoong Pharmaceutical Co. LTD.NCT05505994Written as Dapagliflozin
- Dapagliflozin in Patients With Critical IllnessCompletedPhase 3Hospital Israelita Albert EinsteinNCT05558098Written as Dapagliflozin 10mg Tab
- A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 DiabetesCompletedPhase 2Youngene Therapeutics Inc., Ltd.NCT04956263Written as Dapagliflozin
- Efficacy and Safety of Lima Association in the Control of Type II Diabetes Mellitus.WithdrawnPhase 3EMSNCT03766750Written as Forxiga
- Huangqi Guizhi Wuwu Decoction in CKD Stage 2-4 Diabetic NephropathyStatus unknownNot applicableThe First Affiliated Hospital of Dalian Medical UniversityNCT05418465Written as Dapagliflozin
- A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and DapagliflozinStatus unknownPhase 4Kyung Hee University Hospital at GangdongNCT04706637Written as Dapagliflozin
- Dapagliflozin and Metformin,Alone and in Combination, in Overweight/Obese Prior GDM WomenCompletedPhase 3Woman'sNCT02338193Written as DAPA
Showing 20 of 23.
Codes
What other systems call dapagliflozin · ClinicalTrials.gg INT005279
- MeSH (NLM) C529054dapagliflozinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 1ULL0QJ8UCDAPAGLIFLOZINConfirmed FDA, NLM, Wikidata
- RxNorm 1488564Confirmed FDA, Wikidata
- Wikidata Q409898dapagliflozinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C78126DapagliflozinOne source FDA
- DrugBank DB06292One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C529054 | dapagliflozin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 1ULL0QJ8UC | DAPAGLIFLOZIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1488564 | — | Confirmed FDA, Wikidata |
| Wikidata | Q409898 | dapagliflozin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C78126 | Dapagliflozin | One source FDA |
| DrugBank | DB06292 | — | One source Wikidata |
Also registered as dapagliflozin propanediol (UNII 887K2391VH · RxNorm 1486966).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.